Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

12 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
KRAS mutations in pancreatic cancer: could we talk about a risk factor for the development of thromboembolic phenomena?
Gutiérrez Pérez C, Blanco Abad C, Hontoria Bautista G, Saiz López P, Rodríguez Ledesma I, Espinosa Cabria N, Ramos Reguera I, López Muñoz AM. Gutiérrez Pérez C, et al. Among authors: lopez munoz am. Rev Esp Enferm Dig. 2024 Apr;116(4):236-237. doi: 10.17235/reed.2023.9926/2023. Rev Esp Enferm Dig. 2024. PMID: 37771286 Free article.
Diffuse gastric adenocarcinoma during pregnancy and genetic counseling.
Gutiérrez Pérez C, Rodríguez Ledesma I, Blanco Abad C, Catoya Villa JL, Chivato Martín-Falquina I, Cuenca Zarzuela A, López Muñoz AM. Gutiérrez Pérez C, et al. Among authors: lopez munoz am. Rev Esp Enferm Dig. 2023 Oct;115(10):580-581. doi: 10.17235/reed.2022.9412/2022. Rev Esp Enferm Dig. 2023. PMID: 36562524 Free article.
Fibrolamellar hepatocellular carcinoma treated with chemotherapy and immunotherapy: a rare entity with unique characteristics.
Gutiérrez Pérez C, Pumares González M, Espinosa Cabria N, Cabrera Pinos ML, Calvo Otero L, Valencia Cárdenas LM, Viña Gopar L, López Muñoz AM. Gutiérrez Pérez C, et al. Among authors: lopez munoz am. Rev Esp Enferm Dig. 2025 Jan 20. doi: 10.17235/reed.2025.11021/2024. Online ahead of print. Rev Esp Enferm Dig. 2025. PMID: 39831613
Real-world dosing patterns of regorafenib for patients with metastatic colorectal cancer in Spain: the RE-SEARCH study.
López Muñoz AM, González Flores E, Carral Maseda A, Pimentel Cáceres P, Afonso Gómez R, López López C, Jimeno Maté R, Reina Zoilo JJ, Castañón López C, Salgado Fernández M, Aparicio Urtasun J, Asensio Martínez E, Martín Gómez T. López Muñoz AM, et al. Clin Transl Oncol. 2024 Aug 11. doi: 10.1007/s12094-024-03630-1. Online ahead of print. Clin Transl Oncol. 2024. PMID: 39127984
Dynamic nature of BRAF or KRAS p.G12C mutations in second-line therapy for advanced colorectal cancer patients: do early and late effects exist?
Contreras-Toledo D, Jiménez-Fonseca P, López CL, Montes AF, López Muñoz AM, Vázquez Rivera F, Alonso V, Alcaide J, Salvà F, Covela Rúa M, Guillot M, Martín Carnicero A, Jimeno Mate R, Cameselle García S, Asensio Martínez E, González Astorga B, Fernandez-Diaz AB, González Villaroel P, Virgili Manrique AC, Melián Sosa M, Alonso B, Cousillas Castiñeiras A, Castañón López C, Aparicio J, Carmona-Bayonas A. Contreras-Toledo D, et al. Among authors: lopez munoz am. Br J Cancer. 2024 Mar;130(5):777-787. doi: 10.1038/s41416-023-02563-w. Epub 2024 Jan 8. Br J Cancer. 2024. PMID: 38191609 Free PMC article.
Patient profiles as an aim to optimize selection in the second line setting: the role of aflibercept.
González Astorga B, Salvà Ballabrera F, Aranda Aguilar E, Élez Fernández E, García-Alfonso P, González Flores E, Vera García R, Fernández Montes A, López Muñoz AM, Salud Salvia A. González Astorga B, et al. Among authors: lopez munoz am. Clin Transl Oncol. 2021 Aug;23(8):1520-1528. doi: 10.1007/s12094-021-02568-y. Epub 2021 Feb 25. Clin Transl Oncol. 2021. PMID: 33630242 Free PMC article. Review.
Phase II clinical trial of nab-paclitaxel plus gemcitabine in elderly patients with previously untreated locally advanced or metastatic pancreatic adenocarcinoma: the BIBABRAX study.
Feliu J, Jorge Fernández M, Macarulla T, Massuti B, Albero A, González González JF, Quintero-Aldana G, Delgado-Mingorance JI, Fernández Montes A, García Piernavieja C, Valladares-Ayerbes M, López Muñoz AM, Mondéjar Solís R, Vicente P, Casado Gonzalez E, González Cebrián I, López-Vivanco G. Feliu J, et al. Among authors: lopez munoz am. Cancer Chemother Pharmacol. 2021 Apr;87(4):543-553. doi: 10.1007/s00280-020-04214-w. Epub 2021 Jan 15. Cancer Chemother Pharmacol. 2021. PMID: 33452559 Clinical Trial.
Prognostic Nomogram and Patterns of Use of FOLFIRI-Aflibercept in Advanced Colorectal Cancer: A Real-World Data Analysis.
Fernández Montes A, López López C, Argilés Martínez G, Páez López D, López Muñoz AM, García Paredes B, Gutiérrez Abad D, Castañón López C, Jiménez Fonseca P, Gallego Plazas J, López Doldán MC, Martínez de Castro E, Sánchez Cánovas M, Tobeña Puyal M, Llorente Ayala B, Juez Martel I, López Flores M, Carmona-Bayonas A. Fernández Montes A, et al. Among authors: lopez munoz am. Oncologist. 2019 Aug;24(8):e687-e695. doi: 10.1634/theoncologist.2018-0824. Epub 2019 May 30. Oncologist. 2019. PMID: 31147489 Free PMC article.
12 results